Search research articles
Contact Us
Filters
Showing results (61-70 of 319) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2004
Long-term bisphosphonate treatment of bone metastases from renal cell carcinoma
M Dror Michaelson, Daniel I Rosenthal, Matthew R Smith
Blood
|
March 31, 2009
Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes
Teresita L Arenzana, Matthew R Smith-Raska, Boris Reizis
The New England Journal of Medicine
|
June 28, 2018
Apalutamide and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Margaret K Yu, Eric J Small
Clinical Genitourinary Cancer
|
January 7, 2011
Contemporary therapeutic approaches targeting bone complications in prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Bone
|
July 13, 2010
Treatment and prevention of bone complications from prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Urology
|
February 1, 2003
Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer
Matthew R Smith, Mary Anne Fallon, Melissa J Goode
Clinical Evidence
|
February 27, 2003
Prostate cancer: metastatic
M Dror Michaelson, James A Talcott, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Contribution of androgen deprivation therapy to elevated osteoclast activity in men with metastatic prostate cancer
M Dror Michaelson, Rose M Marujo, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2006
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L Keating, A James O'Malley, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2012
Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer
Philip J Saylor, Edward D Karoly, Matthew R Smith
Page
of 32
Search research articles
Search
Showing results (61-70 of 319) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2004
Long-term bisphosphonate treatment of bone metastases from renal cell carcinoma
M Dror Michaelson, Daniel I Rosenthal, Matthew R Smith
Blood
|
March 31, 2009
Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes
Teresita L Arenzana, Matthew R Smith-Raska, Boris Reizis
The New England Journal of Medicine
|
June 28, 2018
Apalutamide and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Margaret K Yu, Eric J Small
Clinical Genitourinary Cancer
|
January 7, 2011
Contemporary therapeutic approaches targeting bone complications in prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Bone
|
July 13, 2010
Treatment and prevention of bone complications from prostate cancer
Richard J Lee, Philip J Saylor, Matthew R Smith
Urology
|
February 1, 2003
Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer
Matthew R Smith, Mary Anne Fallon, Melissa J Goode
Clinical Evidence
|
February 27, 2003
Prostate cancer: metastatic
M Dror Michaelson, James A Talcott, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Contribution of androgen deprivation therapy to elevated osteoclast activity in men with metastatic prostate cancer
M Dror Michaelson, Rose M Marujo, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2006
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L Keating, A James O'Malley, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2012
Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer
Philip J Saylor, Edward D Karoly, Matthew R Smith
Page
of 32